$ME
23andMe Holding Co. Stock $me

$me Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000180459124000038 Filed on May 30, 2024

Income Statement

Concept	2024 Q1	2024	2023 Q1
Revenue	$64.03M	$219.6M	$92.38M
YoY Change	-30.69%	-26.66%	-8.14%
Cost Of Revenue	$37.00M	$120.3M	$52.40M
YoY Change	-29.39%	-27.11%	-2.07%
Gross Profit	$27.03M	$99.38M	$39.98M
YoY Change	-32.39%	-26.11%	-15.03%
Gross Profit Margin	42.22%	45.25%	43.28%
Selling, General & Admin	$39.23M	$215.4M	$48.54M
YoY Change	-19.18%	-8.71%	-26.67%
% of Gross Profit	145.11%	216.72%	121.4%
Research & Development	$46.72M	$205.4M	$60.72M
YoY Change	-23.05%	-7.74%	20.66%
% of Gross Profit	172.85%	206.65%	151.87%
Depreciation & Amortization	$5.937M	$11.00M	$8.366M
YoY Change	-29.03%	-25.68%	-7.68%
% of Gross Profit	21.96%	11.07%	20.92%
Operating Expenses	$85.95M	$780.8M	$109.3M
YoY Change	-21.33%	70.3%	-6.23%
Operating Profit	-$58.92M	-$681.5M	-$69.27M
YoY Change	-14.95%	110.32%	-0.26%
Interest Expense	$3.042M	$14.33M	$4.369M
YoY Change	-30.37%	48.11%	6726.56%
% of Operating Profit
Other Income/Expense, Net	$5.000K	$506.0K	$174.0K
YoY Change	-97.13%	-644.09%	-242.62%
Pretax Income	-$208.8M	-$666.6M	-$64.73M
YoY Change	222.59%	112.01%	-6.88%
Income Tax	$18.00K	$73.00K	-$633.0K
% Of Pretax Income
Net Earnings	-$208.8M	-$666.7M	-$64.10M
YoY Change	225.8%	113.92%	-7.83%
Net Earnings / Revenue	-326.16%	-303.55%	-69.39%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.43	-$1.40	-$0.14
COMMON SHARES
Basic Shares Outstanding		476.0M shares
Diluted Shares Outstanding		476.0M shares

Balance Sheet

Concept	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$216.5M	$386.8M
YoY Change	-44.04%	-30.07%
Cash & Equivalents	$216.5M	$386.8M
Short-Term Investments
Other Short-Term Assets	$1.794M	$26.00M
YoY Change	-93.1%	-24.5%
Inventory	$12.47M	$10.25M
Prepaid Expenses	$9.296M	$13.24M
Receivables	$3.324M	$1.897M
Other Receivables	$5.751M	$0.00
Total Short-Term Assets	$255.3M	$425.0M
YoY Change	-39.93%	-29.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$28.35M	$38.61M
YoY Change	-26.57%	-22.55%
Goodwill	$0.00	$351.7M
YoY Change	-100.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.868M	$3.021M
YoY Change	-38.17%	16.51%
Total Long-Term Assets	$139.9M	$517.6M
YoY Change	-72.98%	-5.94%
TOTAL ASSETS
Total Short-Term Assets	$255.3M	$425.0M
Total Long-Term Assets	$139.9M	$517.6M
Total Assets	$395.2M	$942.6M
YoY Change	-58.08%	-18.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$11.57M	$12.92M
YoY Change	-10.47%	-65.93%
Accrued Expenses	$42.26M	$66.43M
YoY Change	-36.38%	48.99%
Deferred Revenue	$64.83M	$62.52M
YoY Change	3.69%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$127.3M	$149.4M
YoY Change	-14.78%	-2.5%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.471M	$1.480M
YoY Change	-0.61%	-68.15%
Total Long-Term Liabilities	$1.471M	$1.480M
YoY Change	-0.61%	-68.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$127.3M	$149.4M
Total Long-Term Liabilities	$1.471M	$1.480M
Total Liabilities	$206.6M	$228.7M
YoY Change	-9.63%	-3.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$2.173B	-$1.506B
YoY Change	44.26%	26.09%
Common Stock	$2.362B	$2.221B
YoY Change	6.33%	5.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$188.5M	$713.9M
YoY Change
Total Liabilities & Shareholders Equity	$395.2M	$942.6M
YoY Change	-58.08%	-18.18%

Cashflow Statement

Concept	2024 Q1	2024	2023 Q1
OPERATING ACTIVITIES
Net Income	-$208.8M	-$666.7M	-$64.10M
YoY Change	225.8%	113.92%	-7.83%
Depreciation, Depletion And Amortization	$5.937M	$11.00M	$8.366M
YoY Change	-29.03%	-25.68%	-7.68%
Cash From Operating Activities	-$25.78M	-$164.3M	-$44.96M
YoY Change	-42.65%	-0.65%	27.71%
INVESTING ACTIVITIES
Capital Expenditures	$2.170M	$1.129M	$3.293M
YoY Change	-34.1%	-72.11%	-203.0%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$24.00K	$30.00K	$5.000K
YoY Change	380.0%	500.0%
Cash From Investing Activities	-$2.146M	-$9.626M	-$3.288M
YoY Change	-34.73%	-14.85%	2.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$3.262M
YoY Change		-49.54%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.000M	$3.584M	2.606M
YoY Change	-23.25%	-63.34%	-52.81%
NET CHANGE
Cash From Operating Activities	-25.78M	-$164.3M	-44.96M
Cash From Investing Activities	-2.146M	-$9.626M	-3.288M
Cash From Financing Activities	2.000M	$3.584M	2.606M
Net Change In Cash	-25.93M	-$170.4M	-45.64M
YoY Change	-43.19%	2.3%	38.82%
FREE CASH FLOW
Cash From Operating Activities	-$25.78M	-$164.3M	-$44.96M
Capital Expenditures	$2.170M	$1.129M	$3.293M
Free Cash Flow	-$27.95M	-$165.4M	-$48.25M
YoY Change	-42.07%	-2.35%	50.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-666084000	usd
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	451504377	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	361528119	shares
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001804591
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	me	Contract With Customer Membership Fee Membership Period One ContractWithCustomerMembershipFeeMembershipPeriodOne	P1M
CY2024	me	Contract With Customer Membership Fee Membership Period Two ContractWithCustomerMembershipFeeMembershipPeriodTwo	P3M
CY2024	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal Statement Of Income Extensible List DisposalGroupNotDiscontinuedOperationGainLossOnDisposalStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2023#GeneralAndAdministrativeExpense
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-39587
CY2024	dei	Entity Registrant Name EntityRegistrantName	23ANDME HOLDING CO.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1240344
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	349 Oyster Point Boulevard
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
CY2024	dei	City Area Code CityAreaCode	650
CY2024	dei	Local Phone Number LocalPhoneNumber	938-6300
CY2024	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2024	dei	Trading Symbol TradingSymbol	ME
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	false
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	300000000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	216488000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	386849000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1399000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1399000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3324000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1897000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	12465000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	10247000	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	4792000	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	5376000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16841000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19224000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	255309000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	424992000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28351000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38608000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48894000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56078000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6974000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6974000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	20516000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	15661000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33255000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45520000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	0	usd
CY2023Q1	us-gaap	Goodwill Goodwill	351744000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1868000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3021000	usd
CY2024Q1	us-gaap	Assets Assets	395167000	usd
CY2023Q1	us-gaap	Assets Assets	942598000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	11571000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	12924000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42263000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	66430000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	64827000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	62521000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	8670000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7541000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	127331000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	149416000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	10000000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	67845000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77763000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1471000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1480000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	206647000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	228659000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	49000	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	46000	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2361559000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2220897000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-620000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2173088000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1506384000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	188520000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	713939000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	395167000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	942598000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219638000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299489000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271893000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	164993000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	138948000	usd
CY2022	us-gaap	Gross Profit GrossProfit	132945000	usd
CY2024	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	85600000	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	129772000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	115984000	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	8368000	usd
CY2023	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351744000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	780845000	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-681468000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-324011000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14331000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9676000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	277000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32989000	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	506000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-666631000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-314428000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2772000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3480000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-666704000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-311656000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-217490000	usd
CY2024	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	620000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-799000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	179000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-312455000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-217311000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.40
CY2024	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.40
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.69
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.69
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.60
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.60
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	475982265	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	475982265	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	451504377	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	361528119	shares
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-595619000	usd
CY2022	me	Preferred Stock Conversion Value PreferredStockConversionValue	837351000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	33726000	usd
CY2022	me	Issuance Of Common Stock Upon Merger And Merger Warrant Liability IssuanceOfCommonStockUponMergerAndMergerWarrantLiability	200579000	usd
CY2022	me	Issuance Of Pipe Shares IssuanceOfPIPEShares	250000000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	16831000	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	322845000	usd
CY2022	me	Issuance Of Common Stock For Class A Common Stock Warrant Exercise IssuanceOfCommonStockForClassACommonStockWarrantExercise	42356000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	58624000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	179000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-217490000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	915656000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4203000	usd
CY2023	me	Stock Issued During Period Value Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockUnitsNetOfForfeitures	0	usd
CY2023	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	197000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	6463000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	100269000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-799000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-311656000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	713939000	usd
CY2024	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	909000	usd
CY2024	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	230000	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	117993000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-217490000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32071000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	23699000	usd
CY2024	me	Amortization And Impairment Of Internal Use Software AmortizationAndImpairmentOfInternalUseSoftware	6255000	usd
CY2023	me	Amortization And Impairment Of Internal Use Software AmortizationAndImpairmentOfInternalUseSoftware	4427000	usd
CY2022	me	Amortization And Impairment Of Internal Use Software AmortizationAndImpairmentOfInternalUseSoftware	2449000	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	120209000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	116017000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	57933000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32989000	usd
CY2024	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	10126000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	0	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351744000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-2026000	usd
CY2023	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2022	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	usd
CY2024	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	529000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-77000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-85000	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1427000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1483000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	899000	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2218000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-542000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4262000	usd
CY2024	me	Increase Decrease In Deferred Cost Of Revenue IncreaseDecreaseInDeferredCostOfRevenue	584000	usd
CY2023	me	Increase Decrease In Deferred Cost Of Revenue IncreaseDecreaseInDeferredCostOfRevenue	2325000	usd
CY2022	me	Increase Decrease In Deferred Cost Of Revenue IncreaseDecreaseInDeferredCostOfRevenue	-2219000	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1231000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6653000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10077000	usd
CY2024	me	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	7185000	usd
CY2023	me	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	7393000	usd
CY2022	me	Increase Decrease In Operating Lease Right Of Use Assets IncreaseDecreaseInOperatingLeaseRightOfUseAssets	7078000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1152000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	429000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1820000	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-996000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-24573000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	22856000	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7104000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2671000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8316000	usd
CY2024	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	12307000	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-418000	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8799000	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8790000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8934000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-7054000	usd
CY2024	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-9000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3165000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3635000	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-164319000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-165390000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-166828000	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1129000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4048000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3968000	usd
CY2024	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	30000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	5000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5500000	usd
CY2024	us-gaap	Payments For Software PaymentsForSoftware	8527000	usd
CY2023	us-gaap	Payments For Software PaymentsForSoftware	7262000	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	4505000	usd
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	94165000	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9626000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11305000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108137000	usd
CY2024	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	909000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4203000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	16998000	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3262000	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6464000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2024	me	Payments For Taxes Related To Net Share Settlement Of Equity Awards PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards	-230000	usd
CY2023	me	Payments For Taxes Related To Net Share Settlement Of Equity Awards PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards	-197000	usd
CY2022	me	Payments For Taxes Related To Net Share Settlement Of Equity Awards PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards	0	usd
CY2024	me	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	357000	usd
CY2023	me	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	693000	usd
CY2022	me	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	30642000	usd
CY2024	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	0	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	309720000	usd
CY2024	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	usd
CY2024	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2023	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	44000	usd
CY2024	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	usd
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	usd
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	116000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3584000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9777000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	546004000	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	0	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	385000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-146000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-170361000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-166533000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	270893000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395222000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	561755000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	290862000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	224861000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395222000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	561755000	usd
CY2024	me	Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses PurchasesOfPropertyAndEquipmentDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	97000	usd
CY2023	me	Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses PurchasesOfPropertyAndEquipmentDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	473000	usd
CY2022	me	Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses PurchasesOfPropertyAndEquipmentDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	722000	usd
CY2024	me	Stock Based Compensation Capitalized For Internal Use Software Costs StockBasedCompensationCapitalizedForInternalUseSoftwareCosts	3606000	usd
CY2023	me	Stock Based Compensation Capitalized For Internal Use Software Costs StockBasedCompensationCapitalizedForInternalUseSoftwareCosts	3191000	usd
CY2022	me	Stock Based Compensation Capitalized For Internal Use Software Costs StockBasedCompensationCapitalizedForInternalUseSoftwareCosts	1166000	usd
CY2024	me	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	usd
CY2023	me	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	0	usd
CY2022	me	Reclassification Of Deferred Offering Costs ReclassificationOfDeferredOfferingCosts	3971000	usd
CY2024	me	Assumption Of Merger Warrants Liability AssumptionOfMergerWarrantsLiability	0	usd
CY2023	me	Assumption Of Merger Warrants Liability AssumptionOfMergerWarrantsLiability	0	usd
CY2022	me	Assumption Of Merger Warrants Liability AssumptionOfMergerWarrantsLiability	75415000	usd
CY2024	me	Deferred Offering Costs During The Period Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	1000	usd
CY2023	me	Deferred Offering Costs During The Period Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	45000	usd
CY2022	me	Deferred Offering Costs During The Period Included In Accounts Payable And Accrued Expenses DeferredOfferingCostsDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses	0	usd
CY2024	me	Conversion Of Redeemable Convertible Preferred Stock To Common Stock ConversionOfRedeemableConvertiblePreferredStockToCommonStock	0	usd
CY2023	me	Conversion Of Redeemable Convertible Preferred Stock To Common Stock ConversionOfRedeemableConvertiblePreferredStockToCommonStock	0	usd
CY2022	me	Conversion Of Redeemable Convertible Preferred Stock To Common Stock ConversionOfRedeemableConvertiblePreferredStockToCommonStock	837351000	usd
CY2024	me	Redemption Exercise Of Class A Common Stock Warrants RedemptionExerciseOfClassACommonStockWarrants	0	usd
CY2023	me	Redemption Exercise Of Class A Common Stock Warrants RedemptionExerciseOfClassACommonStockWarrants	0	usd
CY2022	me	Redemption Exercise Of Class A Common Stock Warrants RedemptionExerciseOfClassACommonStockWarrants	42354000	usd
CY2024	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	0	usd
CY2023	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	0	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	322842000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	216488000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	386849000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	553182000	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1399000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1399000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	1599000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6974000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6974000	usd
CY2022Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6974000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	224861000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	395222000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	561755000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	216500000	usd
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	reportable_segment
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Reclassification</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Beginning in fiscal year 2024, the amounts previously presented as revenue and cost of revenue in the consolidated statements of operations and comprehensive loss have been updated to present tangible product and services separately. Prior periods have been reclassified to conform to the current period presentation. The reclassification did not have any impact on total revenue, total cost of revenue, gross profit or net income.</span></div>
CY2024	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fiscal Year</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s fiscal year ends on March 31. References to fiscal year 2024, 2023 and 2022 refer to the fiscal years ended March 31, 2024, 2023 and 2022, respectively.</span></div>
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period and the accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to the determination of standalone selling price for various performance obligations; the estimated expected benefit period for the rate and recognition pattern of breakage revenue for purchases where a saliva collection kit (“Kit”) is never returned for processing; the capitalization and estimated useful life of internal use software; the useful life of long-lived assets; fair value of intangible assets acquired in business combinations; the fair value of reporting units relative to the carrying amount of goodwill; the incremental borrowing rate for operating leases; the fair value of private warrants; stock-based compensation including the determination of the fair value of stock options, annual incentive bonuses payable in the form of restricted stock units (“RSUs”), as well as the fair value of the Company’s common stock prior to the Closing Date of the Merger; the assumptions used in going concern assessments; and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from these estimates, and such differences could be material to the consolidated financial statements.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the fiscal year ended March 31, 2022, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with GlaxoSmithKline plc (“GSK”). The change in estimate was driven by a change in the total project resources resulting in a reduction in the total estimated project hours, which impacted the measurement of progress of the arrangement using the input method. The adjustment increased revenue by $9.0 million, decreased net loss by $9.0 million and decreased the Company’s basic and diluted net loss per share by $0.02 for the fiscal year ended March 31, 2022.</span></div>The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the consolidated financial statements as soon as they become known.
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Concentration of Credit Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments that potentially subject the Company to a concentration of credit risk include cash, cash equivalents and accounts receivable. The Company maintains a majority of its cash and cash equivalents with a single high-quality financial institution, the composition and maturities of which are regularly monitored by the Company. The Company’s revenue and accounts receivable are derived primarily from the United States. See Note 5, “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">” for additional information regarding geographical disaggregation of revenue. The Company grants credit to its customers in the normal course of business, performs credit evaluations of its significant customers on an as-needed basis, and does not require collateral. Concentrations of credit risk are limited as the Company’s trade receivables are primarily related to third </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">parties, which collect its credit card receivables, and large multinational corporations. The Company regularly monitors the aging of accounts receivable balances.</span></div>
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	8400000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	8400000	usd
CY2024	me	Contract With Customer Membership Fee Membership Period Three ContractWithCustomerMembershipFeeMembershipPeriodThree	P12M
CY2024	us-gaap	Advertising Expense AdvertisingExpense	37500000	usd
CY2023	us-gaap	Advertising Expense AdvertisingExpense	49100000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	54700000	usd
CY2024Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	400000	usd
CY2023Q1	us-gaap	Prepaid Advertising PrepaidAdvertising	1600000	usd
CY2022	me	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	309700000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	usd
CY2021Q2	me	Reverse Recapitalization Percentage Of Voting Interests Acquired ReverseRecapitalizationPercentageOfVotingInterestsAcquired	1
CY2021Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	559700000	usd
CY2021Q2	me	Proceed From Issuance Of Common Stock Merger ProceedFromIssuanceOfCommonStockMerger	309700000	usd
CY2021Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	250000000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	33700000	usd
CY2021Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2021Q1	me	Reverse Capitalization Earnout Period After Closing Date ReverseCapitalizationEarnoutPeriodAfterClosingDate	P1Y
CY2021Q1	me	Reverse Recapitalization Earnout Period Stock Price Trigger ReverseRecapitalizationEarnoutPeriodStockPriceTrigger	12.00
CY2021Q1	me	Reverse Capitalization Earnout Period Threshold Trading Days ReverseCapitalizationEarnoutPeriodThresholdTradingDays	20	tradingday
CY2021Q1	me	Reverse Capitalization Shares Threshold Trading Days Period After Business Combination ReverseCapitalizationSharesThresholdTradingDaysPeriodAfterBusinessCombination	30	tradingday
CY2021Q1	me	Reverse Capitalization Earnout Period Number Of Days After Business Combination ReverseCapitalizationEarnoutPeriodNumberOfDaysAfterBusinessCombination	P150D
CY2021Q1	me	Reverse Recapitalization Percentage Of Founder Shares Released From Lock Up ReverseRecapitalizationPercentageOfFounderSharesReleasedFromLockUp	0.70
CY2021Q1	me	Reverse Capitalization Anniversary Of Closing Date ReverseCapitalizationAnniversaryOfClosingDate	P1Y
CY2023Q2	us-gaap	Escrow Deposit EscrowDeposit	6000000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	295025000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-241382000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219638000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299489000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271893000	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	219638000	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	299489000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	271893000	usd
CY2024	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	22100000	usd
CY2023	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	27700000	usd
CY2022	us-gaap	Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized	21900000	usd
CY2024	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	41100000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	46600000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.50
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	reportable_segment
CY2024	us-gaap	Revenues Revenues	219638000	usd
CY2023	us-gaap	Revenues Revenues	299489000	usd
CY2022	us-gaap	Revenues Revenues	271893000	usd
CY2024	me	Adjusted Ebitda AdjustedEBITDA	-175796000	usd
CY2023	me	Adjusted Ebitda AdjustedEBITDA	-161301000	usd
CY2022	me	Adjusted Ebitda AdjustedEBITDA	-150740000	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-666704000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-311656000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-217490000	usd
CY2024	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	14331000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	9676000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	277000	usd
CY2024	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	506000	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-93000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-83000	usd
CY2024	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	0	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-32989000	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	73000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-2772000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3480000	usd
CY2024	me	Depreciation And Amortization Net DepreciationAndAmortizationNet	18033000	usd
CY2023	me	Depreciation And Amortization Net DepreciationAndAmortizationNet	20239000	usd
CY2022	me	Depreciation And Amortization Net DepreciationAndAmortizationNet	18899000	usd
CY2024	me	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	11448000	usd
CY2023	me	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	16486000	usd
CY2022	me	Amortization Of Acquired Intangible Assets AmortizationOfAcquiredIntangibleAssets	7269000	usd
CY2024	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	9968000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	120209000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	116017000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	57933000	usd
CY2024	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2023	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9362000	usd
CY2024	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	98000	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	usd
CY2022	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	9950000	usd
CY2024	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-2375000	usd
CY2023	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
CY2022	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351744000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	1765000	usd
CY2023	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0	usd
CY2022	us-gaap	Loss Contingency Loss In Period LossContingencyLossInPeriod	0	usd
CY2024	me	Adjusted Ebitda Net AdjustedEBITDANet	-175796000	usd
CY2023	me	Adjusted Ebitda Net AdjustedEBITDANet	-161301000	usd
CY2022	me	Adjusted Ebitda Net AdjustedEBITDANet	-150740000	usd
CY2024Q1	me	Fair Value Liabilities Level Two To Level One Transfers Amount FairValueLiabilitiesLevelTwoToLevelOneTransfersAmount	0	usd
CY2023Q1	me	Fair Value Liabilities Level Two To Level One Transfers Amount FairValueLiabilitiesLevelTwoToLevelOneTransfersAmount	0	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351700000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	0	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	9296000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13244000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5751000	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3003000	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	1794000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	2977000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16841000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19224000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	110082000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	113924000	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	81731000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75316000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28351000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38608000	usd
CY2024	us-gaap	Depreciation Depreciation	11000000	usd
CY2023	us-gaap	Depreciation Depreciation	14800000	usd
CY2022	us-gaap	Depreciation Depreciation	16100000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024Q1	me	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	85166000	usd
CY2023Q1	me	Operating Lease Right Of Use Asset Gross OperatingLeaseRightOfUseAssetGross	85408000	usd
CY2024Q1	me	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	36272000	usd
CY2023Q1	me	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	29330000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	48894000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56078000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	0	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	35918000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	25180000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	15402000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	9519000	usd
CY2024Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	20516000	usd
CY2023Q1	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	15661000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	67300000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	34045000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33255000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	81500000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24890000	usd
CY2023Q1	me	Cumulative Impairment Charge CumulativeImpairmentCharge	9968000	usd
CY2023Q1	me	Cumulative Currency Translation CumulativeCurrencyTranslation	1122000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45520000	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12300000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	17300000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7600000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	7919000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7919000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6769000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5006000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	3176000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	2466000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	33255000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	351744000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351744000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	198800000	usd
CY2024Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	152900000	usd
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	351700000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On First Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary	11740000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Second Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary	3458000	usd
CY2024Q1	me	Accrued Payable Current AccruedPayableCurrent	12957000	usd
CY2023Q1	me	Accrued Payable Current AccruedPayableCurrent	17030000	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4266000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5898000	usd
CY2024Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	7221000	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	8839000	usd
CY2024Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	7420000	usd
CY2023Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	21600000	usd
CY2024Q1	me	Accrued Clinical Expenses Current AccruedClinicalExpensesCurrent	9291000	usd
CY2023Q1	me	Accrued Clinical Expenses Current AccruedClinicalExpensesCurrent	11707000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1108000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1356000	usd
CY2024Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	42263000	usd
CY2023Q1	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	66430000	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	8400000	usd
CY2023Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	usd
CY2024	us-gaap	Restructuring Charges RestructuringCharges	8368000	usd
CY2024	us-gaap	Payments For Restructuring PaymentsForRestructuring	8346000	usd
CY2024Q1	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	22000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P7Y
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	13487000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	13650000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	13640000	usd
CY2024	us-gaap	Variable Lease Cost VariableLeaseCost	4403000	usd
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	5422000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	6425000	usd
CY2024	us-gaap	Lease Cost LeaseCost	17890000	usd
CY2023	us-gaap	Lease Cost LeaseCost	19072000	usd
CY2022	us-gaap	Lease Cost LeaseCost	20065000	usd
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	15011000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	14941000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	13490000	usd
CY2024	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7930000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y7M6D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y4M24D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14225000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	15946000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	15472000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11666000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12016000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	29414000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	98739000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	22224000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	76515000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance On Third Anniversary UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary	1900000	usd
CY2024Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Balance Sheet Amount UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount	17098000	usd
CY2024	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	26200000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.94
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70739770	shares
CY2023	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	29900000	usd
CY2022	us-gaap	Unrecorded Unconditional Purchase Obligation Purchases UnrecordedUnconditionalPurchaseObligationPurchases	34700000	usd
CY2021Q2	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2021Q2	me	Number Of Classes Of Authorized Common Stock NumberOfClassesOfAuthorizedCommonStock	3	class_of_stock
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1490000000	shares
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	me	Common Stock Convertible Conversion Ratio CommonStockConvertibleConversionRatio	1
CY2021Q2	me	Common Stock Convertible Conversion Ratio CommonStockConvertibleConversionRatio	1
CY2021Q3	me	Class Of Warrant Or Right Redemption Trading Days ClassOfWarrantOrRightRedemptionTradingDays	10	d
CY2021Q3	me	Class Of Warrant Or Right Redemption Trading Days ClassOfWarrantOrRightRedemptionTradingDays	10	d
CY2021Q3	me	Fractional Shares Issued Upon Exercise Of Warrants FractionalSharesIssuedUponExerciseOfWarrants	0	shares
CY2021Q4	me	Class Of Warrants Or Rights Redemption Price Per Warrant ClassOfWarrantsOrRightsRedemptionPricePerWarrant	0.10
CY2021Q4	me	Number Of Redeemed Warrants Redemption Payment Made To NumberOfRedeemedWarrantsRedemptionPaymentMadeTo	1164142	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	70739770	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	68050752	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	238918589	shares
CY2023Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	163884802	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	68050752	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.20
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10621000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	13097016	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2082713	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.44
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	8325285	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.68
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M6D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	306000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	52562963	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.12
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	306000	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.87
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.42
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.44
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1400000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	4600000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25600000	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	28100000	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y2M12D
CY2024	me	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued During Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedDuringPeriodWeightedAverageExercisePrice	0.61
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	120209000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	116017000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	57933000	usd
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2024	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2024	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2024	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.02
CY2024	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2024	me	Defined Contribution Plan Employer Matching Contribution Employees Gross Pay Amount DefinedContributionPlanEmployerMatchingContributionEmployeesGrossPayAmount	2300000	usd
CY2024	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2700000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1700000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-663740000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-292730000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-221212000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2891000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-21698000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	242000	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-666631000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-314428000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-220970000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2800000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3500000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	17570000	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.03
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.04
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.03
CY2024	me	Effective Income Tax Rate Reconciliation Fair Value Adjustment On Warrants Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentOnWarrantsPercent	0
CY2023	me	Effective Income Tax Rate Reconciliation Fair Value Adjustment On Warrants Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentOnWarrantsPercent	0
CY2022	me	Effective Income Tax Rate Reconciliation Fair Value Adjustment On Warrants Percent EffectiveIncomeTaxRateReconciliationFairValueAdjustmentOnWarrantsPercent	0.03
CY2024	me	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Acquisition Related Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsAcquisitionRelatedValuationAllowancePercent	0
CY2023	me	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Acquisition Related Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsAcquisitionRelatedValuationAllowancePercent	0
CY2022	me	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Acquisition Related Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsAcquisitionRelatedValuationAllowancePercent	0.02
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	-0.11
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses	0
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.06
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.16
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.20
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.01
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.02
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.01
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.02
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	280549000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	262295000	usd
CY2024Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	48027000	usd
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	33709000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4237000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	3865000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	13397000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	18065000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	11498000	usd
CY2024Q1	me	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	17966000	usd
CY2023Q1	me	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	21474000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1192000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	5109000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	303000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	332000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	388350000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	351238000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	364871000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	322104000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	23479000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	29134000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	783000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	892000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	11215000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	13689000	usd
CY2024Q1	me	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	11481000	usd
CY2023Q1	me	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	14117000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	436000	usd
CY2024Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	23479000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	29134000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	usd
CY2024Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	779700000	usd
CY2024	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	42800000	usd
CY2023Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2024	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0	usd
CY2022Q1	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2024Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2023Q1	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2022Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2023Q1	us-gaap	Decrease In Unrecognized Tax Benefits Is Reasonably Possible DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2024Q1	us-gaap	Increase In Unrecognized Tax Benefits Is Reasonably Possible IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible	0	usd
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Name AuditorName	KPMG LLP
CY2024	dei	Auditor Location AuditorLocation	Santa Clara, California
CY2024	dei	Auditor Firm AuditorFirmId	185
CY2024	ecd	Insider Trd Policies Proc Adopted Flag InsiderTrdPoliciesProcAdoptedFlag	true

Files In Submission

Name	View Source	Status
0001804591-24-000038-index-headers.html	Edgar Link	pending
0001804591-24-000038-index.html	Edgar Link	pending
0001804591-24-000038.txt	Edgar Link	pending
0001804591-24-000038-xbrl.zip	Edgar Link	pending
exhibit1028_23andme-second.htm	Edgar Link	pending
exhibit191_23andme-seconda.htm	Edgar Link	pending
exhibit211_23andme-subsidi.htm	Edgar Link	pending
exhibit231consentofkpmgllp.htm	Edgar Link	pending
exhibit97_23andme-compensa.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
me-20240331.htm	Edgar Link	pending
me-20240331.xsd	Edgar Link	pending
me-20240331xexx311.htm	Edgar Link	pending
me-20240331xexx312.htm	Edgar Link	pending
me-20240331xexx321.htm	Edgar Link	pending
me-20240331xexx322.htm	Edgar Link	pending
me-20240331_g1.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
me-20240331_def.xml	Edgar Link	unprocessable
me-20240331_lab.xml	Edgar Link	unprocessable
me-20240331_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
me-20240331_cal.xml	Edgar Link	unprocessable
me-20240331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ME
23andMe Holding Co. Stock $me

2024 Q1 Form 10-K Financial Statement

#000180459124000038 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ME 23andMe Holding Co. Stock $me

2024 Q1 Form 10-K Financial Statement

#000180459124000038 Filed on May 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ME
23andMe Holding Co. Stock $me